CPRX
CPRX
NASDAQ · Biotechnology

Catalyst Pharmaceuticals Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$31.49
+0.01 (+0.03%)
Analyst Consensus
Sell
9
Analysts
Moderate
Coverage
Buy 0 0%
Hold 6 67%
Sell 3 33%
Price Target
Analyst Price Target +59.2% upside
Low Target $36.48
Average Target $50.13
High Target $69.47
Current Price $31.49
Current
$31.49
Target
$50.13
$36.48 $50.13 avg $69.47
Scenario Analysis
Bear Case
$36.48
15.8%
Low target
Base Case
$50.13
+59.2%
Avg target
Bull Case
$69.47
+120.6%
High target
Risk/Reward
7.6x
Highly favorable
Price in Context
52-Week High
$32.56
-3.3% from high
52-Week Low
$19.05
+65.3% from low
50-Day SMA
$23.76
+32.5% vs SMA
200-Day SMA
$22.30
+41.2% vs SMA
RSI (14)
48.5
Neutral
Target vs 52W High
$50.13
+54.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -2.4%
AMGN
Amgen Inc
 Hold 43 47% $190.87 -50.5%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +141.6%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 36 81% $438.34 -13.8%
REGN
Regeneron Pharmaceuticals
 Buy 38 68% $76.80 -90.2%
MRNA
Moderna Inc
 Hold 30 37% $149.45 -3.0%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -61.3%
RVMD
Revolution Medicines Inc
 Strong Buy 28 93% $114.11 -40.2%